drugset / Trial / NCT02950311

Xylitol for Otitis Media

NCT02950311

Phase 2/3 Withdrawn Duke University
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled study of children, age 6 months to 3 years, with a diagnosis of Otis media with effusion (OME) based on examination by a provider at a Duke- affiliated otolaryngology clinic.

Timeline

Start
2017-11-20
Primary completion
2017-11-20
Completion
2017-11-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Xylitol Small molecule Intranasal